PL197005A1 - Sposob wytwarzania nowych pochodnych prostaglandyn - Google Patents

Sposob wytwarzania nowych pochodnych prostaglandyn

Info

Publication number
PL197005A1
PL197005A1 PL19700577A PL19700577A PL197005A1 PL 197005 A1 PL197005 A1 PL 197005A1 PL 19700577 A PL19700577 A PL 19700577A PL 19700577 A PL19700577 A PL 19700577A PL 197005 A1 PL197005 A1 PL 197005A1
Authority
PL
Poland
Prior art keywords
making new
prostaglandin derivatives
new prostaglandin
derivatives
making
Prior art date
Application number
PL19700577A
Other languages
English (en)
Other versions
PL107643B1 (pl
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of PL197005A1 publication Critical patent/PL197005A1/pl
Publication of PL107643B1 publication Critical patent/PL107643B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
PL1977197005A 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn PL107643B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL49325A IL49325A (en) 1976-03-31 1976-03-31 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
PL197005A1 true PL197005A1 (pl) 1978-10-09
PL107643B1 PL107643B1 (pl) 1980-02-29

Family

ID=11048789

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1977210101A PL107544B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn
PL1977197005A PL107643B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn
PL1977210102A PL108289B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandynmethod of producing new derivatives of prostaglandins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1977210101A PL107544B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandyn

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1977210102A PL108289B1 (pl) 1976-03-31 1977-03-29 Sposob wytwarzania nowych pochodnych prostaglandynmethod of producing new derivatives of prostaglandins

Country Status (18)

Country Link
US (1) US4115401A (pl)
JP (1) JPS52142060A (pl)
BE (1) BE852941A (pl)
CA (1) CA1074804A (pl)
CH (2) CH624101A5 (pl)
DD (1) DD130352A5 (pl)
DE (1) DE2714129A1 (pl)
ES (1) ES457385A1 (pl)
FR (1) FR2346332A1 (pl)
GB (1) GB1574246A (pl)
HU (1) HU178040B (pl)
IL (1) IL49325A (pl)
IT (1) IT1075373B (pl)
NL (1) NL7703503A (pl)
NO (1) NO149428C (pl)
PL (3) PL107544B1 (pl)
SE (1) SE417603B (pl)
SU (3) SU676162A3 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7906017L (sv) * 1978-07-11 1980-02-13 Glaxo Group Ltd Prostanoida foreningar
US4320136A (en) * 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
AP2002002555A0 (en) 1999-12-22 2002-06-30 Pfizer Prod Inc EP4 Receptor selective agonists in the treatment of osteoporosis.
EA200300379A1 (ru) 2000-11-27 2003-08-28 Пфайзер Продактс Инк. Селективные агонисты рецептора ep4 в лечении остеопороза
PL215425B1 (pl) * 2001-07-16 2013-12-31 Ono Pharmaceutical Co Pochodna pirolidonu, srodek farmaceutyczny zawierajacy te pochodna i jej zastosowanie
JP2004521954A (ja) 2001-07-16 2004-07-22 エフ.ホフマン−ラ ロシュ アーゲー Ep4受容体作用薬としてのプロスタグランジン類似体
JP4273407B2 (ja) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Ep4アゴニストを有効成分とする骨量低下疾患の治療剤
AU2003211574A1 (en) 2002-03-05 2003-09-16 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
EP1490055A1 (en) * 2002-03-18 2004-12-29 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
CA2511255C (en) * 2003-01-10 2009-04-07 F. Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones

Also Published As

Publication number Publication date
FR2346332A1 (fr) 1977-10-28
DE2714129A1 (de) 1977-10-13
NO149428C (no) 1984-04-18
BE852941A (fr) 1977-09-28
IL49325A (en) 1979-11-30
ES457385A1 (es) 1978-02-01
NL7703503A (nl) 1977-10-04
HU178040B (en) 1982-02-28
SE7703698L (sv) 1977-10-01
JPS52142060A (en) 1977-11-26
SE417603B (sv) 1981-03-30
SU715019A3 (ru) 1980-02-05
SU676162A3 (ru) 1979-07-25
NO771134L (no) 1977-10-03
IT1075373B (it) 1985-04-22
US4115401A (en) 1978-09-19
PL107643B1 (pl) 1980-02-29
SU837321A3 (ru) 1981-06-07
CH624101A5 (pl) 1981-07-15
DD130352A5 (de) 1978-03-22
CA1074804A (en) 1980-04-01
CH628032A5 (fr) 1982-02-15
PL108289B1 (pl) 1980-03-31
PL107544B1 (pl) 1980-02-29
GB1574246A (en) 1980-09-03
FR2346332B1 (pl) 1980-05-09
IL49325A0 (en) 1976-05-31
NO149428B (no) 1984-01-09

Similar Documents

Publication Publication Date Title
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
PL201586A1 (pl) Sposob wytwarzania nowych zwiazkow spiro-hydantionowych
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL199603A1 (pl) Sposob wytwarzania nowych pochodnych kwasu pirolokarboksylowego-1
PL200289A1 (pl) Sposob wytwarzania zwiazkow 3-chlorocefemowych
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
PL200124A1 (pl) Sposob wytwarzania nowych pochodnych pirolidonu
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL197045A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL104866B1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu